19 results
8-K
APLS
Apellis Pharmaceuticals Inc
22 Jan 24
Departure of Directors or Certain Officers
8:00am
served as the Company’s Chief Commercial Officer since November 2018. From March 2010 to October 2018 he served in a variety of leadership roles at Biogen
8-K
a1g 5piojq
9 Sep 21
Other Events
4:10pm
8-K
EX-99.1
j36na uy7
27 Oct 20
Sobi obtains global co-development and exclusive ex-U.S. commercialization rights for systemic pegcetacoplan, a targeted C3 therapy
7:17am
- Prev
- 1
- Next